Active substance (DCI)
- natalizumab
history (5)
-
9/8/21
TYSABRI 150 mg (natalizumab)
CAV : -
10/3/18
TYSABRI (-/ natalizumab/ natalizumab ((MAMMIFERE/SOURIS/CELLULES NSO)))
CAV : -
6/21/17
TYSABRI (-/ natalizumab/ natalizumab ((MAMMIFERE/SOURIS/CELLULES NSO)))
-
2/29/12
TYSABRI (-/ natalizumab/ natalizumab ((MAMMIFERE/SOURIS/CELLULES NSO)))
CAV : -
1/17/07
TYSABRI
CAV :
Technical information
ATC code
- L04AA23
Manufacturer
BIOGEN FRANCE SAS
Presentation
TYSABRI 150 mg, solution injectable en seringue préremplie
Boite de 2 - (Code CIP : 34009 550 803 8 1)
TYSABRI 300 mg, solution à diluer pour perfusion (code CIS : 68722564)
1 flacon(s) en verre de 15 ml - (Code CIP : 34009 569 967 7 3)